ERBB2 and breast cancer: The immunohistochemical detection of BiP in two small cohorts of luminal breast cancers disclosed a novel finding, the effect of endocrine treatment on BiP subcellular localization and confirmed that increased BiP expression is associated with metastasis and HER2 expression.